Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Sells $256,350.00 in Stock

Share on StockTwits

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Dennis Helling sold 5,000 shares of the stock in a transaction dated Friday, January 17th. The shares were sold at an average price of $51.27, for a total transaction of $256,350.00. Following the completion of the transaction, the director now owns 15,216 shares of the company’s stock, valued at approximately $780,124.32. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Dennis Helling also recently made the following trade(s):

  • On Monday, November 25th, Dennis Helling sold 5,000 shares of Tabula Rasa HealthCare stock. The shares were sold at an average price of $45.00, for a total transaction of $225,000.00.

Shares of NASDAQ TRHC opened at $57.01 on Thursday. The stock has a market cap of $1.22 billion, a price-to-earnings ratio of -31.85 and a beta of 1.51. Tabula Rasa HealthCare Inc has a 52 week low of $37.41 and a 52 week high of $68.00. The company’s 50-day moving average price is $46.84 and its 200 day moving average price is $51.87. The company has a current ratio of 2.22, a quick ratio of 2.13 and a debt-to-equity ratio of 1.32.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.06) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.01. The firm had revenue of $74.27 million for the quarter, compared to analysts’ expectations of $75.37 million. Tabula Rasa HealthCare had a negative net margin of 13.46% and a positive return on equity of 0.50%. As a group, research analysts expect that Tabula Rasa HealthCare Inc will post -0.23 earnings per share for the current year.

A number of brokerages have recently issued reports on TRHC. BidaskClub upgraded shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a report on Saturday, January 18th. Wells Fargo & Co cut their price target on shares of Tabula Rasa HealthCare from $55.00 to $50.00 and set an “equal weight” rating for the company in a report on Wednesday, January 8th. ValuEngine downgraded shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “buy” rating in a report on Wednesday, November 13th. Piper Jaffray Companies cut their price target on shares of Tabula Rasa HealthCare from $78.00 to $66.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Finally, Zacks Investment Research upgraded shares of Tabula Rasa HealthCare from a “sell” rating to a “buy” rating and set a $54.00 price target for the company in a report on Friday, January 10th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $66.79.

A number of hedge funds and other institutional investors have recently modified their holdings of TRHC. Intrinsic Edge Capital Management LLC grew its stake in Tabula Rasa HealthCare by 173.3% in the 2nd quarter. Intrinsic Edge Capital Management LLC now owns 358,673 shares of the company’s stock valued at $17,909,000 after acquiring an additional 227,453 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Tabula Rasa HealthCare by 18.2% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 1,315,216 shares of the company’s stock valued at $65,669,000 after acquiring an additional 202,683 shares during the last quarter. Russell Investments Group Ltd. grew its stake in Tabula Rasa HealthCare by 939.3% in the 3rd quarter. Russell Investments Group Ltd. now owns 188,480 shares of the company’s stock valued at $10,355,000 after acquiring an additional 170,345 shares during the last quarter. Point72 Asset Management L.P. grew its stake in Tabula Rasa HealthCare by 892.4% in the 3rd quarter. Point72 Asset Management L.P. now owns 188,231 shares of the company’s stock valued at $10,341,000 after acquiring an additional 169,263 shares during the last quarter. Finally, Macquarie Group Ltd. grew its stake in Tabula Rasa HealthCare by 26.3% in the 2nd quarter. Macquarie Group Ltd. now owns 728,027 shares of the company’s stock valued at $36,350,000 after acquiring an additional 151,779 shares during the last quarter. 99.17% of the stock is currently owned by hedge funds and other institutional investors.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

See Also: Most Volatile Stocks – What Investors Need to Know to Maximize ROI

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: Analysts Anticipate Verint Systems Inc.  Will Post Earnings of $1.16 Per Share
Zacks: Analysts Anticipate Verint Systems Inc. Will Post Earnings of $1.16 Per Share
Brokerages Expect Outfront Media Inc  to Post $0.72 Earnings Per Share
Brokerages Expect Outfront Media Inc to Post $0.72 Earnings Per Share
$377.44 Million in Sales Expected for Verint Systems Inc.  This Quarter
$377.44 Million in Sales Expected for Verint Systems Inc. This Quarter
Equitable Financial  and Capitol Federal Financial  Critical Comparison
Equitable Financial and Capitol Federal Financial Critical Comparison
EncryptoTel [WAVES]  Price Up 4.4% Over Last Week
EncryptoTel [WAVES] Price Up 4.4% Over Last Week
BnkToTheFuture Market Cap Hits $11.82 Million
BnkToTheFuture Market Cap Hits $11.82 Million


© 2006-2020 Ticker Report